glp 1 semaglutide or tirzepatide GLP-1 vs. GLP-1 + GIP: What's the Difference for your Metabolism? Announcing semaglutide and tirzepatide PRICE

Research-grade materials lack regulatory oversight for human use, potentially compromising both safety and efficacy

In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium

Finally, its widely available in supplement form and often used to improve skin elasticity, relieve joint pain, and protect against bone loss ( However, many people are unsure whether collagen can harm their kidney health or increase their risk of kidney stones

To establish a clinical parameter-based model, we trained a random forest survival model using only clinical variables (age, sex, BMI, tumor type, treatment group and stage)